fulltext.pdf 107 KB
Recent evidence suggests that the AKT1-GSK3b signalling cascade partially mediates dopaminedependent behaviours. In relation to the pathophysiology of schizophrenia or methamphetamine (Meth) use disorder, AKT1 is a good candidate gene for such conditions. For schizophrenia, positive associations of SNPs and AKT1 haplotypes were reported in US and Japanese samples. To evaluate the association between AKT1 and Meth-use disorder, we conducted a case-control study of Japanese samples (182 patients and 437 controls). A positive association between a SNP and haplotypes was found, and the ‘signal’ SNP was the same SNP found to be associated with US schizophrenia, but not with Japanese schizophrenia. Our results indicate that AKT1 may play a possible role in the development of Meth-use disorder. Further investigation of these associations, together with evidence from previous animal studies, may open the way to elucidation of the pathophysiology of this condition.
Published with permission from the copyright holder.>br /> This is published in International Journal of Neuropsychopharmacology , 2006 Feb, volume 9, Issue.1, pp 77-81.
Publisher URL: http://dx.doi.org/10.1017/S1461145705005481
Direct access to Thomson Web of Science record
Copyright © 2006 Cambridge University Press All rights reserved.
International Journal of Neuropsychopharmacology
|Web of Science KeyUT|